Cara A. Mosley, Ph.D.
Affiliations: | Chemistry | Emory University, Atlanta, GA |
Area:
Medicinal, Bioorganic, Synthetic Organic, ComputationalGoogle:
"Cara Mosley"Mean distance: 9.82
Parents
Sign in to add mentorDennis C. Liotta | grad student | 2009 | Emory | |
(Design, synthesis, and biological evaluation of subunit-selective N-methyl-D-aspartate receptor antagonists.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Swanger SA, Vance KM, Acker TM, et al. (2017) A novel negative allosteric modulator selective for GluN2C/2D-containing NMDA receptors inhibits synaptic transmission in hippocampal interneurons. Acs Chemical Neuroscience |
Mosley CA, Acker TM, Hansen KB, et al. (2010) Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists. Journal of Medicinal Chemistry. 53: 5476-90 |
Mosley CA, Myers SJ, Murray EE, et al. (2009) Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors. Bioorganic & Medicinal Chemistry. 17: 6463-80 |
Mosley CA, Wilson LJ, Wiseman JM, et al. (2009) Recent patents regarding the discovery of small molecule CXCR4 antagonists. Expert Opinion On Therapeutic Patents. 19: 23-38 |
Shoji M, Sun A, Kisiel W, et al. (2008) Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa. Journal of Drug Targeting. 16: 185-97 |
Mosley CA, Liotta DC, Snyder JP. (2007) Highly active anticancer curcumin analogues. Advances in Experimental Medicine and Biology. 595: 77-103 |